Based on the analysis of Daxor's profitability, liquidity, and operating efficiency, Daxor may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Daxor's Short and Long Term Debt is relatively stable compared to the past year. Key indicators impacting Daxor's financial strength include:
Investors should never underestimate Daxor's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Daxor's cash flow, debt, and profitability to make informed and accurate decisions about investing in Daxor.
Net Income
266,608
Daxor
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Average Payables
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Average Inventory
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Average Receivables
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change In Cash
Free Cash Flow
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
End Period Cash Flow
Begin Period Cash Flow
Depreciation
Sale Purchase Of Stock
Change In Working Capital
Other Cashflows From Financing Activities
Total Cash From Financing Activities
Dividends Paid
Total Cashflows From Investing Activities
Other Cashflows From Investing Activities
Change To Inventory
Change To Account Receivables
Change To Liabilities
Change To Netincome
Investments
Net Borrowings
Change To Operating Activities
Stock Based Compensation
Issuance Of Capital Stock
Total Assets
Short Long Term Debt Total
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Cash
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Cash And Short Term Investments
Net Receivables
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Other Stockholder Equity
Total Liab
Total Current Assets
Other Current Liab
Total Current Liabilities
Accounts Payable
Property Plant And Equipment Gross
Accumulated Other Comprehensive Income
Common Stock Total Equity
Common Stock
Short Term Investments
Other Current Assets
Treasury Stock
Property Plant Equipment
Inventory
Current Deferred Revenue
Short Term Debt
Long Term Debt
Net Tangible Assets
Short Long Term Debt
Capital Surpluse
Long Term Investments
Net Invested Capital
Depreciation And Amortization
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Cost Of Revenue
Research Development
Net Income Applicable To Common Shares
Selling And Marketing Expenses
Net Income From Continuing Ops
Tax Provision
Interest Income
Net Interest Income
Probability Of Bankruptcy
Understanding current and past Daxor Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Daxor's financial statements are interrelated, with each one affecting the others. For example, an increase in Daxor's assets may result in an increase in income on the income statement.
Daxor competes with InfuSystems Holdings, Meihua International, Repro Med, LeMaitre Vascular, and Precision Optics,. Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corp is traded on NASDAQ Exchange in the United States.
The reason investors look at the income statement is to determine what Daxor's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Daxor's current stock value. Our valuation model uses many indicators to compare Daxor value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Daxor competition to find correlations between indicators driving Daxor's intrinsic value. More Info.
Daxor is rated # 5 in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Daxor's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Daxor by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Daxor Systematic Risk
Daxor's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Daxor volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Daxor correlated with the market. If Beta is less than 0 Daxor generally moves in the opposite direction as compared to the market. If Daxor Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Daxor is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Daxor is generally in the same direction as the market. If Beta > 1 Daxor moves generally in the same direction as, but more than the movement of the benchmark.
Daxor Thematic Clasifications
Daxor is part of Medical Equipment investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Daxor Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Daxor's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Daxor growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Daxor help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Daxor. We use our internally-developed statistical techniques to arrive at the intrinsic value of Daxor based on widely used predictive technical indicators. In general, we focus on analyzing Daxor Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Daxor's daily price indicators and compare them against related drivers.
When running Daxor's price analysis, check to measure Daxor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daxor is operating at the current time. Most of Daxor's value examination focuses on studying past and present price action to predict the probability of Daxor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daxor's price. Additionally, you may evaluate how the addition of Daxor to your portfolios can decrease your overall portfolio volatility.